nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00905	0.0761	CbGeAlD
Trihexyphenidyl—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00895	0.0752	CbGeAlD
Trihexyphenidyl—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00871	0.0733	CbGeAlD
Trihexyphenidyl—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00814	0.0685	CbGeAlD
Trihexyphenidyl—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00756	0.0636	CbGeAlD
Trihexyphenidyl—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00729	0.0613	CbGeAlD
Trihexyphenidyl—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00707	0.0595	CbGeAlD
Trihexyphenidyl—CHRM4—brain—attention deficit hyperactivity disorder	0.00692	0.0582	CbGeAlD
Trihexyphenidyl—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00689	0.0579	CbGeAlD
Trihexyphenidyl—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00681	0.0573	CbGeAlD
Trihexyphenidyl—CHRM5—brain—attention deficit hyperactivity disorder	0.00541	0.0455	CbGeAlD
Trihexyphenidyl—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00486	0.0408	CbGeAlD
Trihexyphenidyl—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00468	0.0393	CbGeAlD
Trihexyphenidyl—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00442	0.0372	CbGeAlD
Trihexyphenidyl—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00426	0.0358	CbGeAlD
Trihexyphenidyl—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00396	0.0333	CbGeAlD
Trihexyphenidyl—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00381	0.032	CbGeAlD
Trihexyphenidyl—CHRM2—brain—attention deficit hyperactivity disorder	0.00371	0.0312	CbGeAlD
Trihexyphenidyl—CHRM1—brain—attention deficit hyperactivity disorder	0.00338	0.0284	CbGeAlD
Trihexyphenidyl—CHRM3—brain—attention deficit hyperactivity disorder	0.00302	0.0254	CbGeAlD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000852	0.000967	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000851	0.000966	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000849	0.000963	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000841	0.000954	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000841	0.000954	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000841	0.000954	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000837	0.00095	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000836	0.000949	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000833	0.000946	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000832	0.000944	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000829	0.000941	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000825	0.000937	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000815	0.000925	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000815	0.000925	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000809	0.000919	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000807	0.000916	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000805	0.000914	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000805	0.000914	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000799	0.000907	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000796	0.000904	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000792	0.000899	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000789	0.000896	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000783	0.000889	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000782	0.000887	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00078	0.000885	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000767	0.00087	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000764	0.000867	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000757	0.000859	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000754	0.000855	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000751	0.000853	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00075	0.000851	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000744	0.000845	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000744	0.000844	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000742	0.000842	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000742	0.000842	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00074	0.000839	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000735	0.000834	CbGpPWpGaD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000733	0.000832	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000732	0.000831	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000732	0.000831	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000731	0.00083	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00072	0.000818	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000701	0.000796	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000693	0.000787	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000691	0.000785	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00069	0.000783	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000685	0.000777	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000656	0.000744	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000654	0.000742	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000649	0.000736	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000646	0.000734	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00064	0.000727	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000622	0.000706	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000617	0.000701	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000615	0.000699	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00061	0.000692	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000605	0.000687	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000603	0.000684	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000603	0.000684	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000601	0.000682	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000597	0.000678	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000595	0.000676	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000595	0.000675	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000584	0.000663	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000582	0.000661	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000576	0.000654	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000574	0.000651	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000572	0.000649	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000572	0.000649	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000567	0.000643	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000567	0.000643	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000567	0.000643	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000565	0.000641	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000565	0.000641	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000565	0.000641	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000561	0.000636	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00056	0.000635	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00056	0.000635	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000559	0.000634	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000553	0.000628	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000549	0.000623	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000549	0.000623	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000548	0.000621	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000548	0.000621	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000544	0.000617	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000542	0.000615	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000541	0.000614	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000528	0.000599	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000526	0.000597	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000525	0.000596	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000521	0.000592	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000521	0.000591	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000505	0.000573	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000494	0.00056	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000494	0.00056	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000492	0.000559	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000491	0.000558	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000489	0.000555	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000487	0.000553	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000486	0.000551	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000484	0.000549	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000484	0.000549	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000481	0.000546	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000481	0.000546	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000479	0.000544	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000475	0.000539	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000473	0.000536	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000472	0.000536	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00047	0.000534	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000469	0.000532	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000461	0.000523	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000461	0.000523	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000459	0.000521	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000455	0.000516	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000452	0.000513	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000444	0.000504	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000443	0.000503	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000443	0.000502	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000439	0.000499	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000437	0.000496	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000431	0.00049	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000426	0.000483	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000424	0.000481	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000419	0.000476	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000418	0.000475	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000418	0.000474	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000414	0.00047	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000413	0.000469	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000402	0.000456	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000395	0.000448	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000386	0.000438	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000385	0.000437	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000384	0.000436	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000381	0.000432	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000381	0.000432	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00038	0.000431	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000376	0.000427	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00037	0.00042	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000369	0.000418	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000367	0.000416	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000366	0.000416	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000365	0.000415	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000365	0.000414	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000362	0.000411	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000341	0.000387	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00034	0.000385	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000336	0.000382	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000334	0.000379	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000333	0.000378	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000332	0.000377	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000331	0.000376	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00033	0.000375	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00033	0.000375	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000329	0.000373	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000329	0.000373	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000327	0.000371	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000326	0.00037	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000324	0.000368	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000324	0.000368	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000323	0.000367	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000323	0.000367	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00032	0.000364	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00032	0.000364	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00032	0.000363	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000319	0.000363	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000319	0.000362	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000318	0.000361	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000317	0.00036	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000316	0.000359	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000314	0.000357	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00031	0.000352	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000309	0.000351	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000308	0.00035	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000305	0.000347	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0003	0.00034	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000299	0.000339	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000298	0.000339	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000297	0.000338	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000297	0.000337	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000296	0.000336	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000295	0.000334	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000295	0.000334	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000294	0.000333	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000292	0.000331	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000291	0.00033	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000291	0.00033	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00029	0.000329	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000287	0.000326	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000281	0.000319	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000279	0.000317	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000273	0.000309	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000273	0.000309	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000271	0.000308	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000271	0.000308	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00027	0.000307	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00027	0.000306	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000268	0.000304	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000268	0.000304	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000263	0.000298	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00026	0.000295	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000293	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000255	0.000289	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000251	0.000285	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000249	0.000283	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000247	0.00028	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000244	0.000277	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000237	0.000269	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000227	0.000258	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000225	0.000255	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000224	0.000254	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000222	0.000252	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000218	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000209	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000208	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000207	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000206	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000197	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000196	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000194	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00019	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000189	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000187	0.000213	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000183	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000182	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00018	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000177	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000176	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000175	0.000198	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000174	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000173	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000172	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000172	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000171	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00017	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000166	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000165	0.000187	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000164	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00016	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00016	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000159	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000158	0.000179	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000111	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.81e-05	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.44e-05	9.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	7.08e-05	8.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.94e-05	6.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.92e-05	6.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.86e-05	6.66e-05	CbGpPWpGaD
